Status:
UNKNOWN
Monitoring of the Post-vaccination Immune Response to COVID-19 Among Hospital Staff
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Hospital Staff
Vaccined Againt COVID-19
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Vaccination against COVID-19 is a major public health issue to control the epidemic and reduce the number of severe infections and deaths. Three vaccines currently received use authorization in France...
Detailed Description
* All medical, para-medical, medico-technical and administrative staff of the Clermont-Ferrand university hospital will be informed of the protocol through intra-hospital communication. The inclusion ...
Eligibility Criteria
Inclusion
- Adult person, man or woman, staff of the Clermont-Ferrand University Hospital (medical or paramedical, medico-technical or administrative caregiver), having received the second dose of vaccine (or the single dose if the single-dose vaccination schedule) against COVID- 19 3 months +/- 15 days before the inclusion visit, as part of the national vaccination campaign, regardless of the type of vaccine administered.
- For the subgroup included before vaccination (study of the pre-vaccination cellular response): Adult person, man or woman, staff of Clermont-Ferrand University Hospital (medical or paramedical, medico-technical or administrative caregiver), receiving the 1st injection on the same day or in the 7 days before the inclusion visit, regardless of the type of vaccine administered
- Commitment to respect the schedule of visits provided for in the research protocol
- Able to give informed consent to participate in research
- Affiliation to a social security scheme
Exclusion
- Pregnancy or breastfeeding in progress at inclusion, or planned during follow-up
- Person under guardianship, guardianship or legal protection
- Whether the vaccine received was experimental or not authorized
- Refusal of participation
Key Trial Info
Start Date :
May 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04896788
Start Date
May 19 2021
End Date
May 1 2024
Last Update
May 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clermont-Ferrand University Hospital
Clermont-Ferrand, AURA, France, 63000